Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss, Noise-Induced | 11 | 2022 | 46 | 5.590 |
Why?
|
| Cochlea | 18 | 2020 | 169 | 3.480 |
Why?
|
| Hair Cells, Auditory | 17 | 2019 | 60 | 3.340 |
Why?
|
| Mice, Inbred CBA | 20 | 2019 | 107 | 1.750 |
Why?
|
| Deafness | 3 | 2022 | 64 | 1.650 |
Why?
|
| Hair Cells, Auditory, Outer | 9 | 2022 | 33 | 1.370 |
Why?
|
| Hearing Loss | 6 | 2022 | 154 | 1.350 |
Why?
|
| Noise | 6 | 2016 | 153 | 1.270 |
Why?
|
| Antioxidants | 6 | 2016 | 304 | 1.250 |
Why?
|
| Cell Death | 8 | 2022 | 329 | 1.210 |
Why?
|
| Oxidative Stress | 7 | 2015 | 718 | 1.070 |
Why?
|
| Mice | 30 | 2020 | 8474 | 1.060 |
Why?
|
| Gentamicins | 7 | 2013 | 68 | 0.950 |
Why?
|
| Ear, Inner | 4 | 2016 | 47 | 0.940 |
Why?
|
| Animals | 37 | 2022 | 20881 | 0.890 |
Why?
|
| Aging | 5 | 2011 | 911 | 0.890 |
Why?
|
| RNA, Small Interfering | 5 | 2022 | 434 | 0.870 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2022 | 48 | 0.860 |
Why?
|
| Organ of Corti | 3 | 2019 | 21 | 0.840 |
Why?
|
| Hair Cells, Auditory, Inner | 2 | 2019 | 19 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 331 | 0.720 |
Why?
|
| Microdissection | 1 | 2019 | 15 | 0.690 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 168 | 0.660 |
Why?
|
| Azepines | 1 | 2019 | 15 | 0.660 |
Why?
|
| Anti-Bacterial Agents | 10 | 2020 | 1026 | 0.650 |
Why?
|
| Presbycusis | 2 | 2011 | 84 | 0.650 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 33 | 0.650 |
Why?
|
| Quinazolines | 1 | 2019 | 70 | 0.640 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 9 | 2016 | 49 | 0.630 |
Why?
|
| Signal Transduction | 6 | 2016 | 2689 | 0.610 |
Why?
|
| Apoptosis | 4 | 2017 | 1641 | 0.610 |
Why?
|
| Hydroxamic Acids | 2 | 2016 | 84 | 0.600 |
Why?
|
| Gene Transfer Techniques | 2 | 2022 | 173 | 0.600 |
Why?
|
| Autophagy | 2 | 2017 | 208 | 0.560 |
Why?
|
| Auditory Threshold | 8 | 2019 | 206 | 0.560 |
Why?
|
| Actins | 3 | 2019 | 249 | 0.550 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2013 | 110 | 0.510 |
Why?
|
| Sirolimus | 2 | 2017 | 118 | 0.510 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 116 | 0.500 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 32 | 0.500 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 21 | 0.480 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 700 | 0.480 |
Why?
|
| Nebramycin | 3 | 2020 | 3 | 0.470 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 30 | 0.470 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 223 | 0.460 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 1293 | 0.430 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2012 | 8 | 0.430 |
Why?
|
| Cell Survival | 2 | 2013 | 901 | 0.430 |
Why?
|
| Acoustic Stimulation | 5 | 2016 | 206 | 0.420 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2012 | 19 | 0.420 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 157 | 0.410 |
Why?
|
| RNA Interference | 1 | 2012 | 266 | 0.400 |
Why?
|
| Male | 22 | 2019 | 37321 | 0.400 |
Why?
|
| Neuropeptides | 1 | 2012 | 106 | 0.390 |
Why?
|
| Transcription Factors | 1 | 2015 | 753 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 626 | 0.370 |
Why?
|
| Energy Metabolism | 1 | 2012 | 222 | 0.370 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2009 | 6 | 0.350 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2009 | 32 | 0.330 |
Why?
|
| Dietary Supplements | 1 | 2011 | 332 | 0.330 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 108 | 0.320 |
Why?
|
| Kanamycin | 5 | 2013 | 11 | 0.320 |
Why?
|
| Quality of Life | 1 | 2016 | 1515 | 0.310 |
Why?
|
| Histones | 1 | 2009 | 111 | 0.310 |
Why?
|
| Aspirin | 2 | 2006 | 295 | 0.300 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 137 | 0.290 |
Why?
|
| Spiral Ganglion | 4 | 2016 | 47 | 0.280 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 134 | 0.260 |
Why?
|
| Aminoglycosides | 3 | 2012 | 54 | 0.260 |
Why?
|
| Tyrosine | 3 | 2015 | 196 | 0.240 |
Why?
|
| Genetic Therapy | 2 | 2022 | 291 | 0.230 |
Why?
|
| Aldehydes | 3 | 2015 | 34 | 0.210 |
Why?
|
| Genetic Vectors | 2 | 2022 | 312 | 0.210 |
Why?
|
| Dependovirus | 1 | 2022 | 34 | 0.210 |
Why?
|
| Transduction, Genetic | 1 | 2022 | 81 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2022 | 4 | 0.210 |
Why?
|
| Hearing | 2 | 2019 | 133 | 0.210 |
Why?
|
| Caspase 9 | 2 | 2014 | 31 | 0.200 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 499 | 0.200 |
Why?
|
| Hair | 1 | 2022 | 46 | 0.200 |
Why?
|
| Cisplatin | 3 | 2011 | 192 | 0.200 |
Why?
|
| Time Factors | 4 | 2016 | 4655 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2012 | 447 | 0.190 |
Why?
|
| Superoxide Dismutase | 3 | 2006 | 149 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 2550 | 0.180 |
Why?
|
| Aminoacyltransferases | 1 | 2019 | 4 | 0.180 |
Why?
|
| Glycosides | 1 | 2019 | 14 | 0.180 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2012 | 23 | 0.170 |
Why?
|
| Epithelium | 1 | 2019 | 172 | 0.170 |
Why?
|
| Lim Kinases | 1 | 2019 | 3 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1745 | 0.170 |
Why?
|
| KCNQ Potassium Channels | 1 | 2019 | 8 | 0.160 |
Why?
|
| 3T3 Cells | 1 | 2019 | 124 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 98 | 0.160 |
Why?
|
| Escherichia coli | 1 | 2020 | 368 | 0.160 |
Why?
|
| Calcium | 1 | 2022 | 929 | 0.150 |
Why?
|
| Synapses | 2 | 2019 | 222 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2009 | 1200 | 0.150 |
Why?
|
| Neomycin | 1 | 2017 | 56 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2016 | 202 | 0.140 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 8 | 0.140 |
Why?
|
| Drug Administration Routes | 1 | 2016 | 25 | 0.140 |
Why?
|
| Histone Code | 1 | 2016 | 5 | 0.140 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2016 | 31 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 328 | 0.140 |
Why?
|
| Models, Biological | 2 | 2011 | 981 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 9 | 0.130 |
Why?
|
| Receptors, AMPA | 1 | 2016 | 99 | 0.130 |
Why?
|
| Acetylcysteine | 2 | 2017 | 296 | 0.130 |
Why?
|
| Hydroxybenzoates | 2 | 2013 | 9 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 99 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2016 | 190 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2016 | 178 | 0.120 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 1070 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2012 | 37 | 0.120 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 8 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2015 | 137 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 114 | 0.120 |
Why?
|
| Caspase 8 | 1 | 2014 | 40 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 108 | 0.120 |
Why?
|
| Free Radical Scavengers | 2 | 2013 | 112 | 0.120 |
Why?
|
| Cell Line | 3 | 2017 | 1752 | 0.120 |
Why?
|
| Ear Ossicles | 1 | 2013 | 2 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2015 | 209 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2014 | 152 | 0.110 |
Why?
|
| Necrosis | 1 | 2014 | 239 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 710 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 659 | 0.110 |
Why?
|
| Tympanic Membrane | 1 | 2012 | 25 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2011 | 305 | 0.110 |
Why?
|
| Punctures | 1 | 2012 | 35 | 0.110 |
Why?
|
| Ear, Middle | 1 | 2012 | 32 | 0.110 |
Why?
|
| Drug Interactions | 3 | 2009 | 289 | 0.110 |
Why?
|
| Organ Culture Techniques | 2 | 2012 | 122 | 0.110 |
Why?
|
| Injections | 1 | 2012 | 119 | 0.100 |
Why?
|
| Ribosomes | 1 | 2012 | 23 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 1174 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 80 | 0.100 |
Why?
|
| Mutation | 2 | 2016 | 1213 | 0.100 |
Why?
|
| Mitochondria | 2 | 2017 | 643 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2011 | 237 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 81 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2011 | 233 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 314 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2011 | 1664 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2012 | 163 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2015 | 617 | 0.090 |
Why?
|
| Carbohydrate Conformation | 2 | 2020 | 25 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 682 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2009 | 954 | 0.090 |
Why?
|
| Humans | 6 | 2022 | 68618 | 0.090 |
Why?
|
| Threonine | 1 | 2009 | 47 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2020 | 226 | 0.090 |
Why?
|
| Cytosol | 1 | 2009 | 123 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2006 | 73 | 0.080 |
Why?
|
| Acetylation | 1 | 2009 | 94 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.080 |
Why?
|
| Cell Count | 1 | 2009 | 248 | 0.080 |
Why?
|
| Cochlear Microphonic Potentials | 1 | 2008 | 15 | 0.080 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2008 | 16 | 0.080 |
Why?
|
| Stria Vascularis | 1 | 2008 | 31 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1054 | 0.080 |
Why?
|
| Age Factors | 2 | 2011 | 1864 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 1038 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1851 | 0.070 |
Why?
|
| Catalase | 2 | 2005 | 85 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2673 | 0.070 |
Why?
|
| Neurons | 1 | 2012 | 881 | 0.070 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2006 | 10 | 0.070 |
Why?
|
| Phosphatidylinositols | 1 | 2006 | 40 | 0.070 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 32 | 0.070 |
Why?
|
| Free Radicals | 1 | 2006 | 65 | 0.070 |
Why?
|
| Vestibule, Labyrinth | 1 | 2006 | 19 | 0.070 |
Why?
|
| Salicylates | 2 | 2005 | 22 | 0.070 |
Why?
|
| Female | 6 | 2016 | 38074 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 5717 | 0.060 |
Why?
|
| Trauma, Nervous System | 1 | 2005 | 6 | 0.060 |
Why?
|
| Sodium Salicylate | 1 | 2004 | 1 | 0.060 |
Why?
|
| Adult | 2 | 2016 | 21403 | 0.060 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2003 | 15 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2003 | 18 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2005 | 432 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2006 | 1738 | 0.050 |
Why?
|
| Aged | 1 | 2016 | 14862 | 0.050 |
Why?
|
| Biomarkers | 1 | 2006 | 1593 | 0.050 |
Why?
|
| Ethers | 1 | 2019 | 13 | 0.040 |
Why?
|
| Carbohydrate Sequence | 1 | 2019 | 45 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 240 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 290 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2002 | 307 | 0.040 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2019 | 16 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 2012 | 124 | 0.040 |
Why?
|
| Middle Aged | 1 | 2016 | 21147 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1033 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2006 | 3705 | 0.040 |
Why?
|
| Autophagy-Related Proteins | 1 | 2017 | 17 | 0.040 |
Why?
|
| Adenine | 1 | 2017 | 46 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2016 | 20 | 0.030 |
Why?
|
| Tubulin | 1 | 2016 | 60 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 58 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 176 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 396 | 0.030 |
Why?
|
| Superoxides | 2 | 2006 | 70 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2016 | 183 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 2004 | 104 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2012 | 7 | 0.030 |
Why?
|
| Mycobacterium | 1 | 2012 | 12 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2012 | 60 | 0.030 |
Why?
|
| Drug Design | 1 | 2012 | 107 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 181 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 509 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2012 | 133 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 326 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 175 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 193 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 246 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 631 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2006 | 155 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2006 | 84 | 0.020 |
Why?
|
| DNA Replication Timing | 1 | 2005 | 1 | 0.020 |
Why?
|
| Synaptotagmin I | 1 | 2005 | 1 | 0.020 |
Why?
|
| Synaptotagmins | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2005 | 34 | 0.020 |
Why?
|
| Rats | 2 | 2004 | 5300 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 60 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2005 | 31 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 132 | 0.020 |
Why?
|
| Protective Agents | 1 | 2005 | 36 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 44 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 114 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 81 | 0.010 |
Why?
|
| Polymers | 1 | 2006 | 244 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2005 | 128 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 567 | 0.010 |
Why?
|
| Hydroxyl Radical | 1 | 2003 | 17 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 48 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 791 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 295 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 94 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 230 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2006 | 597 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 2002 | 6 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2002 | 24 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2002 | 65 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 931 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2002 | 114 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 118 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 371 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 2791 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 1536 | 0.010 |
Why?
|